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PfPK7 is an orphan protein kinase of Plasmodium falciparum with maximal homology to MEK3/6 and to
fungal protein kinase A proteins in its C-terminal and N-terminal regions, respectively. We showed previously
that recombinant PfPK7 is active on various substrates but is unable to phosphorylate the Plasmodium
falciparum mitogen-activated protein kinase homologues, suggesting that it is not a MEK functional homo-
logue. Using a reverse genetics approach to investigate the function of this enzyme in live parasites, we now
show that PfPK7 parasite clones display phenotypes at two stages of their life cycle: first, a decrease in the
rate of asexual growth in erythrocytes associated with a lower number of daughter merozoites generated per
schizont, and second, a dramatic reduction in the ability to produce oocysts in the mosquito vector. A normal
asexual growth rate and the ability to produce oocysts are restored if a functional copy of the PfPK7 gene is
reintroduced into the PfPK7 parasites. Hence, PfPK7 is involved in a pathway that regulates parasite
proliferation and development.
Malaria parasites still impose a huge burden on the devel-
oping world, with 40% of the world’s population at risk and an
estimated 350 million to 500 million clinical cases annually.
This translates into 1 million to 3 million deaths each year,
mostly among young children in sub-Saharan Africa. In view of
the growing concern caused by the emergence and spread of
drug resistance in Plasmodium falciparum, the species respon-
sible for the vast majority of lethal malaria cases, the develop-
ment of novel control agents is an urgent task (18). Research
into novel drug targets has been immensely facilitated by the
availability of genomic sequence databases (14).
Malaria pathogenesis is caused by the asexual multiplica-
tion of parasites in erythrocytes. After invading a red blood
cell, the infecting merozoite develops into a so-called ring
form, which grows to form a trophozoite, in which DNA
synthesis is initiated around 30 h postinvasion. Several
rounds of genome replication and nuclear mitoses lead to
the formation of multinucleated schizonts, which eventually
(48 h postinvasion) rupture and release 16 to 32 new mero-
zoites. Some merozoites, after invading the host’s red blood
cells, arrest their cell cycle and differentiate into male or
female gametocytes. These sexual cells do not contribute to
pathology but are required for transmission to the mosquito
vector (for a review, see reference 26). Upon ingestion by
the insect, they complete their development to gametes; for
male gametocytes, this involves three rounds of division
leading to eight flagellated gametes, a process known as
exflagellation. Fertilization and subsequent meiosis lead to
the development of a motile ookinete, which crosses the
midgut epithelium and establishes itself as an oocyst at the
basal lamina of the epithelium. Sporogony, the asexual gen-
eration of several thousand sporozoites, occurs within the
oocyst. Sporozoites invade the insect’s salivary glands, which
are primed to infect a new human host during a subsequent
blood meal taken by the mosquito. Injected sporozoites first
establish an infection inside a hepatocyte, which results in
the generation of several thousand merozoites (exoerythro-
cytic schizogony) able to infect erythrocytes.
Mitogen-activated protein kinase (MAPK) pathways play
crucial roles in the control of eukaryotic cell proliferation in
response to various extra- or intracellular stimuli (for a review,
see reference 20). Despite the presence of two MAPK-encod-
ing genes, Pfmap-1 (6, 12, 15) and Pfmap-2 (7), the P. falcip-
arum genome does not possess orthologues of the MAPK
kinase (also called MEK, for MAP/ERK kinase) family (1, 28),
raising the question of the mode of activation of Pfmap-1 and
Pfmap-2. PfPK7 (PlasmoDB database identifier PFB0605w) is
the P. falciparum enzyme with the highest level of homology to
MEKs (8). However, although the C-terminal lobe of PfPK7
displays maximal homology to the MEK family, its N-terminal
lobe is more closely related to that of fungal cyclic AMP-
dependent kinases. We previously showed that despite possess-
ing protein kinase activity in vitro on a variety of substrates,
PfPK7 was not able to phosphorylate the two plasmodial
MAPK homologues and was therefore unlikely to be a MEK
functional homologue (8).
Here we present a reverse genetics study in which parasite
clones with a disrupted PfPK7 gene were generated to address
the question of the function of the atypical kinase in the P.
falciparum life cycle. This revealed an important role for the
enzyme in the control of parasite proliferation and develop-
ment.
* Corresponding author. Mailing address: INSERM U609, Well-
come Centre for Molecular Parasitology, University of Glasgow, Glas-
gow Biomedical Research Centre, 120 University Place, Glasgow G12
8TA, Scotland, United Kingdom. Phone: 44 141 330 6201. Fax: 44 141
330 5422. E-mail: cdoer001@udcf.gla.ac.uk.
 Published ahead of print on 14 December 2007.
279
 at EPFL Scientific inform
ation and libraries on April 14, 2010 
e
c.a
sm
.o
rg
D
ow
nloaded from
 
MATERIALS AND METHODS
Vector construction and genotyping of PfPK7 clones. The PfPK7 knockout
plasmid (pCAM-PK7) was generated by inserting an amplicon corresponding to
the central region of the catalytic domains of the enzyme into the pCAM-BSD
vector (25), which contains a cassette conferring resistance to blasticidin. A fragment
spanning nucleotides 111 to 1315 (numbered according to the PlasmoDB entry) was
obtained using forward (GGGGGGATCCATAACATAATTATATTATTATA
TATGT) and reverse (GCGGCCGCAGGGGGCATGAATTCATAGGTACC)
primers carrying BamHI and NotI sites (underlined), respectively, and inserted
into pCAM-BSD.
The complementation plasmid pCHD-PK7 was obtained by the insertion of a
cDNA encoding the entire PfPK7 coding region (8) into the pHGB vector (27),
thus placing PfPK7 expression under the control of the PfHsp86 promoter
present in the vector. The resulting plasmid was used as a donor vector in a
recombination reaction with the pCHD plasmid, which contains a cassette con-
ferring resistance to the antifolate drug WR99210. After recombination, the final
complementation pCHD-PK7 plasmid carries a resistance cassette and contains
the PfPK7 cDNA under the control of the PfHsp86 promoter.
Parasite culture and transfection. Asexual stages of the 3D7 clone of Plasmo-
dium falciparum were grown as described previously (7), using 0.5% Albumax I
instead of human serum (23). Transfection was carried out by the electropora-
tion of ring stage parasites with 60 g of plasmid DNA, as previously described
(25). Blasticidin was added to a final concentration of 2.5 g/ml 48 h posttrans-
fection to select for transformed parasites. Blasticidin-resistant parasites ap-
peared after 3 to 4 weeks of culture, and their genotype was evaluated by PCR
to verify that integration had occurred at the target locus (see Results). The
parasites were then cloned by limiting dilution in 96-well plates (0.25 to 1
parasite/well) (24), and clones were selected by genotype screening using PCR
(see Fig. 1).
For the complementation of the PfPK7 clone B9, blasticidin-resistant B9
parasites were retransfected with the pCHD-PK7 plasmid. Forty-eight hours
postelectroporation, dual selection (2.5 g/ml blasticidin plus 5 nM WR99210)
was applied. Parasites resistant to both compounds appeared after 4 to 5 weeks
and were used (without cloning) for genotype verification and phenotype char-
acterization.
Genotype characterization. (i) PCR. For the detection of integration at the 5
and 3 flanks of the insert, the wild-type gene, and the episomes, various primer
combinations were used (see Fig. 1 for primer numbers) to amplify PCR prod-
ucts from genomic DNA (see below for the DNA extraction protocol). The
sequences for the primers are as follows: primer 1, GGAGGGGGATCCATG
AAGGATATTTTATCAAT; primer 2, ATTTATTAAACTGCAGCCC; primer
3, AAGCTGGAGCTCCACCGC; and primer 4, ACCCAAACTCCATATATC
CACCTTTGC. Primers 1 and 4 correspond to PfPK7 sequences, and primers 2
and 3 correspond to pCAM-BSD vector sequences flanking the insertion site.
(ii) Southern blotting. Genomic DNA isolated from 3D7 and from PfPK7
(clone B9) parasites was obtained as follows: a pellet of parasites obtained by
saponin lysis was treated with 150 g/ml proteinase K and 2% sodium dodecyl
sulfate at 55°C for 2 h. The DNA was precipitated with ethanol and 0.3 M sodium
acetate after phenol-chloroform-isoamyl alcohol (25:24:1) extraction. Five mi-
crograms of DNA was then digested with EcoRV and NcoI, fractionated on a
0.8% agarose gel, and transferred to a Hybond N membrane, according to the
manufacturer’s procedures (Amersham). The PfPK7 amplicon (the same one
that had been inserted into pCAM-BSD [see above]) was used as a fluorescein-
labeled probe, and chemoluminescence detection was performed by following
the manufacturer’s protocol (Amersham).
Western blotting. Parasite pellets were obtained from asynchronous cultures
(6 to 8% parasitemia) of either wild-type or mutant parasites by saponin lysis.
The pellets were lysed by boiling them for 3 min in Laemmli buffer. After
centrifugation in a microcentrifuge, the supernatants were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. Western blotting was carried
out as previously described, using antibodies against PfPK7 (8) and Pfcyc-4 (17).
Detection was performed using the ECL chemiluminescence system by following
the manufacturer’s protocol (Amersham).
Mosquito infections. Gametocytes of each parasite line were grown in vitro
and fed to Anopheles gambiae mosquitoes through membrane feeders as de-
scribed previously (3), using medium containing 10% human serum instead of
Albumax. Mosquitoes were dissected 10 days postinfection for microscopic anal-
ysis of oocyst infection of the midgut. DNA was extracted from oocyst-positive
midguts by use of previously published methods (21). Oocyst prevalences be-
tween parasite clones were compared using 2 tests or Fisher’s exact test as
appropriate. Oocyst densities between parasite clones were compared by 2
comparisons of oocyst distributions fitted to negative binomials by use of the
Genmod procedure with the SAS v.8e for Windows statistical package (2).
RESULTS
Disruption of the PfPK7 gene. Our strategy for knocking out
Plasmodium genes encoding protein kinases relies on a single
crossover homologous recombination (9). A plasmid based on
the pCAM-BSD vector (25), containing an insert correspond-
ing to the central region of the PfPK7 catalytic domain next to
a cassette conferring resistance to blasticidin, was transferred
by electroporation into asexual parasites of the 3D7 clone of P.
falciparum. Homologous recombination at the PfPK7 locus was
expected to generate a pseudo-diploid configuration, with both
truncated copies lacking essential regions of the catalytic do-
main (Fig. 1A). The parasite is haploid, and PfPK7 is a single-
copy gene, which makes only one round of drug selection
necessary to obtain a null mutant. PCR examination of the
genotypes of blasticidin-resistant parasite populations at the
PfPK7 locus, using various primers to distinguish (i) the wild-
type locus, (ii) the 5 integration event, (iii), the 3 integration
event, and (iv) the episomal form of the transfected plasmid,
demonstrated that the populations did include parasites where
integration had occurred (Fig. 1B, “uncloned resistant” panel).
Clones were obtained by dilution and screened by PCR for a
disrupted PfPK7 locus. Two clones, B9 and C4, were selected
for further characterization. PCR analysis of clone B9 (Fig.
1B) showed that (i) these parasites had lost the wild-type gene
(lane 4), (ii) amplicons with expected sizes for 5 and 3 inte-
gration events were recovered (lanes 1 and 2), and (iii) the
episome was still present in the cloned parasites (lane 3) (this
band might also arise from integrated plasmid concatemers).
The same results were obtained with clone C4 (data not
shown). To independently ascertain integration at the proper
locus, we performed Southern blotting of DNA from wild-type
3D7 and clone B9 by using a PfPK7 probe, which gave the
expected bands (Fig. 1C; see Fig. 1A for predicted fragment
sizes). The expected bands were also detected during blotting
performed with genomic DNA from clone C4 (data not
shown). Taken together, the PCR and Southern blot analyses
show that the PfPK7 locus has been disrupted in clone B9. We
next verified by Western blot analysis whether this disruption
resulted in the disappearance of the PfPK7 protein. As shown
in Fig. 2A (left panel), the PfPK7 protein was undetectable in
both the B9 and the C4 clones (lanes 2 and 3), although it was
readily detected in the 3D7 wild-type parasite (lane 1). Anti-
bodies against an unrelated protein (the Pfcyc-4 cyclin [17])
used as a loading control yielded similar signals in all lanes.
Complementation of the knockout parasites with a plasmid
expressing PfPK7 cDNA. In order to be able to formally assign
any phenotype of the PfPK7 parasites (see below) to the
absence of the PfPK7 enzyme, we generated “complemented
B9” parasites that expressed PfPK7 from an episome. This was
achieved by transfecting (PfPK7) B9 parasites with plasmid
pCHD-PK7, in which a cDNA of the full-length PfPK7 coding
region was placed under the control of the Hsp86 promoter
present in the pCHD vector (27), which is selectable using the
antifolate drug WR99210. Parasites resistant to both blastici-
din and WR99210 were obtained, and PCR analysis confirmed
that the parasites contained the shorter (intronless) PfPK7
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FIG. 1. Gene disruption and genotyping. (A) Disruption of the PfPK7 locus. Primers used for the detection of integration events are indicated
by numbered arrows (see Materials and Methods for the primer sequences). ATP, the glycine triad in subdomain I of the catalytic domain that
is required for the proper orientation of the ATP molecule; PE, the proline-glutamate dipeptide in subdomain VIII in which the E residue is
required for the structural stability of the enzyme; BSD, blasticidin resistance cassette. (B) PCR analysis of the PfPK7 locus. Genomic DNA from
wild-type 3D7, from the uncloned blasticidin-resistant population, from the PfPK7 clone B9, and from B9 parasites complemented with pCHD-PK7 was
isolated and subjected to PCR analysis. The following primer pairs were used (see panel A): primers 1 and 3 to detect integration at the 5 end of the
insert (lane 1); primers 2 and 4 to detect integration at the 3 end of the insert (lane 2); primers 2 and 3 to detect the episome (lane 3); and primers 1
and 4 to detect the wild-type locus (lane 4). The expected sizes of the amplicons are indicated on the right. (C) Southern blot analysis of the PfPK7 locus
in 3D7 and PfPK7 (clone B9) parasites. Genomic DNA was cleaved with EcoRV and NcoI, transferred, and probed with a PfPK7 probe (see Materials
and Methods). The sizes of the bands are indicated on the right (see panel A for their identities). WT, wild type.
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cDNA, while the genomic locus was still disrupted (Fig. 1B,
right panel, lane 4). The restoration of PfPK7 protein expres-
sion in the complemented parasites to levels similar to those
observed in wild-type 3D7 was evidenced by Western blot
analysis (Fig. 2A, right panel; compare lanes 1 and 4).
Asexual growth rate is decreased in PfPK7 parasites. That
we obtained parasite clones unable to express PfPK7 demon-
strates that this enzyme is not essential for erythrocytic
schizogony. However, monitoring the progression of para-
sitemia of the PfPK7 B9 clone in parallel with that of wild-
type 3D7 allowed us to detect a defect in the kinase knockout
parasites: the growth rate of the latter was significantly lower
(by a factor of approximately 2) than that of 3D7 (Fig. 2B).
This was also observed with clone C4 (not shown). That this
lower rate was indeed due to the absence of PfPK7 in the
mutated clone was ascertained by complementation: clone B9
parasites in which PfPK7 expression was restored from the
pCHD-PK7 episome displayed a growth rate similar to that of
the wild-type parasites (Fig. 2B).
The decrease in the parasite growth rate might be caused by
FIG. 2. Phenotype of PfPK7 parasites during the erythrocyte asexual cycle. (A) Western blot analysis. Top panels, anti-PfPK7 antibodies were
used; bottom panels, anti-Pfcyc-4 antibodies (loading control) were used. Two experiments are depicted, using two PfPK7 clones (B9 and C4).
The right panel also shows the reexpression of PfPK7 in clone B9 complemented with a plasmid driving the expression of PfPK7 cDNA. The sizes
of the comigrating markers are indicated in kDa on the left. WT, wild type. (B) Growth rate of the PfPK7 B9 clone compared to that of wild-type
3D7 and of the B9 clone complemented with pCHD-PK7. Parasitemia was measured for three independent cultures over 5 days. Ten different
fields from Giemsa-stained smears were counted for each time point, and the mean parasitemia was determined. Standard errors of the means are
indicated by error bars. (C) Numbers of nuclei per segmenter in populations (200 segmenters) of the PfPK7 clone, wild-type 3D7, and the B9
clone complemented with pCHD-PK7. The data are from one experiment, for which 100 segmenters were examined independently by two different
observers. Standard errors of the means are indicated by error bars. The panel at the right provides a more visual depiction of the differences
between the clones. This experiment was repeated twice with similar results. (D) Giemsa-stained schizonts from the B9 clone and from B9 parasites
complemented with pCHD-PK7.
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the lengthening of one or more phases of the asexual cycle, by
a lower number of merozoites generated per schizont, or by
decreased infectivity of daughter merozoites. To address this
question, we examined the distribution of segmenters (mature
schizonts) with a given number of nuclei in B9 and wild-type
3D7 parasites. While there was no obvious difference in the
morphologies of schizonts and segmenters from the two lines
(see Fig. 2D), we found that the average number of nuclear
bodies per segmenter was shifted toward lower values in
PfPK7 (B9) parasites than in wild-type 3D7 parasites. Like
the decrease in growth rate, this phenotype was rescued by
complementation with pCHD-PK7 (Fig. 2C).
PfPK7 parasites do not complete sporogony in the mos-
quito vector. We next tested the ability of the PfPK7 parasites
to undergo the sexual cycle. The PfPK7 clones B9 and C4
were able to undergo gametocytogenesis, male gamete produc-
tion (exflagellation), and female gametogenesis (qualitative
observations; data not shown). Mature gametocytes from wild-
type 3D7 and PfPK7 clones B9 and C4 were fed to Anopheles
gambiae mosquitoes through membrane feeders. Ten days
postfeeding, the mosquito midguts were isolated and examined
for the presence of oocysts (Table 1). The wild-type parasites
were able to establish an infection and produce oocysts in 21/24
mosquitoes, giving a prevalence of 88% (Table 1, experiment
1). In contrast, the number of oocysts produced by PfPK7
parasites appeared to be dramatically reduced, to zero in this
experiment (0/25 mosquitoes infected with C4 and 0/4 with B9;
0% prevalence) and to almost zero in a subsequent experiment
(Table 1, experiment 2; 1/30 mosquitoes infected with B9,
giving a 3.3% prevalence; see below). It is well established that
prolonged cultivation of asexual stages of malaria parasites can
result in the loss of infectivity for the mosquito. Therefore, in
order to verify that the defect in oocyst formation was due to
the absence of PfPK7 in the mutant clones rather than to the
loss of infectivity caused by prolonged cultivation, the feeding
experiment was repeated with the addition of (i) mock-trans-
fected wild-type 3D7, which had been in continuous culture for
the same length of time as the B9 clone, and (ii) B9 parasites
complemented with pCHD-PK7 (Table 1, experiment 2). The
(long-cultured) mock-transfected line displayed reduced infec-
tivity compared with that of fresh 3D7, as expected. Most
importantly, complementation of the B9 clone with pCHD-
PK7 restored the ability of the clone to produce oocysts to
levels statistically indistinguishable from those obtained with
the mock-transfected line (P values of 0.79 for prevalence and
0.22 for oocyst intensity) (see Table 1, experiment 2; for a
statistical analysis of the data, see Table 2). It follows that the
PfPK7 enzyme is required for mature oocyst formation.
Although no oocysts were observed, parasite material was
detected by PCR amplification of the Pfmdr1 gene from the
midguts of mosquitoes infected by B9 parasites 10 days after
infection, as was the case with two positive controls: wild-type
parasites (not shown) and clone H4, a PfPK7 blasticidin-
resistant clone lacking another kinase (Pfmap-1) and able to
generate oocysts as efficiently as the wild type (9) (Fig. 3). This
suggests that the parasites were able to cross the midgut epi-
thelium, as no parasite material survives in the midgut lumen
for this length of time (L. Ranford-Cartwright, unpublished
observation; see Discussion).
FIG. 3. Evidence that PfPK7 parasites cross the mosquito midgut.
Parasite DNA from the midguts of mosquitoes infected with clone B9
(lanes 1 and 2; two different mosquitoes), clone C4 (lane 3), and H4,
a PfPK7 clone that produces wild-type levels of oocysts (lane 5), was
amplified 10 days postfeeding. Lane 4, negative control (midgut from
an uninfected mosquito). Nested-PCR amplification of the Pfmdr1
gene was performed as described previously (10); the expected ampli-
con size in kb is indicated on the right. Wild-type 3D7 gave a signal
similar to that yielded by the H4 clone (lane 5; not shown).
TABLE 1. Oocyst infections in Anopheles gambiae mosquitoes at
day 10 postfeeding
Expt and parasite
No. of mosquitoes
infected/total no.
dissected
Prevalence of
infection (%)
No. of
oocysts in
infected
mosquitoes
Expt 1
3D7 PfPK7 clone B9 0/4 0 0
3D7 PfPK7 clone C4 0/25 0 0
3D7 wild type 21/24 88 1–9
Expt 2
3D7 wild type 27/29 93 1–45
3D7 mock-transfected
control
12/30 40 1–3
3D7 PfPK7 clone B9 1/30 3 4
3D7 PfPK7 clone B9
 pCHD-PK7
11/30 37 1–5
TABLE 2. Statistical comparisons of oocyst prevalence and intensity
Expt and parasites compared
P value
Oocyst
prevalence
Oocyst
intensity
Expt 1
3D7 wild type vs 3D7 PfPK7
clone B9
0.0002 NDa
3D7 wild type vs 3D7 PfPK7
clone C4
0.0001 ND
Expt 2
3D7 wild type vs 3D7 mock-
transfected
0.0001b 0.0001b
3D7 mock-transfected vs 3D7
PfPK7 clone B9
0.0006b 0.0037b
3D7 mock-transfected vs 3D7
PfPK7 clone B9 
pCHD-PK7
0.79 0.22
3D7 PfPK7 clone B9 vs 3D7
PfPK7 clone B9 
pCHD-PK7
0.0012b 0.0012b
a ND, not done; the distribution does not fit a negative binomial adequately
(all negative in one group).
b The P value indicates a significant difference.
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DISCUSSION
Parasites lacking PfPK7 multiply more slowly than wild-type
parasites. It may seem counterintuitive that such impaired par-
asites can be selected from the transfected population, as one
would predict that they should be outgrown in the uncloned
transformed population by parasites carrying the episome but
retaining a wild-type PfPK7 locus. Our tentative explanation is
as follows: before integration into the PfPK7 locus has oc-
curred, the episome may not be segregated evenly through the
entire progeny of a given schizont; indeed, a single copy of the
episome per schizont may be sufficient to confer resistance to
blasticidin. It follows that only a fraction of the merozoite
progeny may harbor the selectable marker, causing a low
growth rate (which is what we typically observe in the early
stages post-transfection/selection). However, once the con-
struct is integrated into the target locus, the progeny in its
entirety is blasticidin resistant and may therefore compete suc-
cessfully with parasites carrying the episome but no integrated
copy of the construct, even if the associated phenotype is a
multiplication rate that is lower than that of the wild-type
parasite.
The slow-asexual-growth phenotype of PfPK7 parasites
(Fig. 2B) is clearly associated with a lower number of nuclear
bodies observed both in mixed schizonts (not shown) and in
segmenter (Fig. 2C) populations. This demonstrates that mero-
zoite release is not dependent on the completion of the bio-
genesis of a fixed number of merozoites. Although we did not
detect any striking differences in the length of the various
phases of the asexual cycle or in invasion efficiency by using
standard methods (examination of Giemsa-stained slides
throughout the cycle), it is difficult to determine whether the
smaller number of daughter merozoites per schizont in B9
parasites is sufficient to quantitatively explain the low growth
rate. Indeed, the level of resolution of the standard methods
we used might be too low to allow the detection of subtle
differences in these parameters. In this respect, a recent com-
parative study of the asexual-cycle parameters of P. falciparum
clones Dd2 and Hb3 reported that (i) the parasite growth rate
of Dd2 is approximately twice as high as that of Hb3 and (ii)
Dd2 segmenters contain on average more nuclei than Hb3
segmenters (22). These results are strikingly similar to the
difference documented here between parasite clones that ex-
press PfPK7 and those that do not. In addition, Reilly et al.
(22) also detected subtle differences in the lengths of the asex-
ual cycle (Dd2 completing its cycle marginally more quickly
than Hb3) and in the invasion capabilities of the merozoites
from the two clones. Could this also be the case with the
PfPK7 parasites? Work is in progress to investigate these
parameters in more detail. The authors of the Dd2/Hb3 study
(22) mention cyclins and cyclin-dependent kinases (classical
regulators of the eukaryotic cell cycle) as potential mediators
of the phenotype and propose to conduct a genetic study of a
Dd2  Hb3 cross (from which progeny clones are already
available) to detect the linkage disequilibrium associated with
the growth rate phenotype and thereby identify implicated
genes. Although it is possible (and even likely) that this is
mediated through multigene regulation, our data suggest that
PfPK7 is a strong candidate. Polymorphism data from Plas-
moDB do not include any striking difference in the PfPK7
coding regions from 3D7, Hb3, and Dd2, but this is not con-
clusive with respect to parameters such as spatiotemporal ex-
pression and activity levels of the enzyme. It would certainly be
of interest to compare PK7 expression and activity levels in
Dd2 and Hb3 and to monitor the effect of the overexpression
of the gene in Hb3 on growth rate and merozoite production.
The molecular basis for the slow growth of the PfPK7
parasites remains unexplained. Ongoing comparative tran-
scriptome and proteome analyses, as well as the identification
of PfPK7 substrates and interactors, are likely to shed some
light on this issue. In the first instance, it will be of interest to
determine whether any item in the growing list of putative
Plasmodium cell cycle regulators available as recombinant pro-
teins (e.g., cyclins or cyclin-dependent kinases) act as PfPK7
substrates in vitro.
Interestingly, other P. falciparum genes whose disruption has
been shown to cause slow growth are two genes encoding
aspartic proteases of the plasmepsin family; the longer parasite
doubling time observed in the plasmepsin knockout parasites
was associated with a decreased level of progeny (16) (as de-
scribed here for the PfPK7 knockout parasites) rather than to
a lengthening of the asexual cycle (as was shown, for example,
for Plasmodium berghei clones lacking the translation elonga-
tion factor eeF1A [13]). The similarity in phenotypes might
reflect a functional link between PfPK7 and the plasmepsins,
an intriguing possibility; such functional links between pro-
teases and protein kinases have indeed been documented (for
an example, see reference 19).
With respect to the block in the sporogonic cycle displayed
by the PfPK7 parasites, the B9 clone was able to generate
gametocytes and to undergo male and female gametogenesis,
as determined by qualitative observations (data not shown).
Thus, the block that causes the inability of PfPK7 parasites to
form oocysts most likely occurs between gametogenesis and
oocyst maturation. Positive PCR detection of parasite material
from mosquitoes 10 days postfeeding (Fig. 3) suggests (but
does not formally demonstrate) that ookinetes are able to
escape the midgut environment. Two studies support this prop-
osition. First, human DNA (which is more abundant than par-
asite DNA!) is not amplifiable from blood-fed mosquitoes
from 100 h postfeeding (4), presumably a consequence of the
excretion of the remains of the blood meal bolus from the
mosquito, which occurs around 2 days after the blood feeding,
and of the degradation of the material remaining in the stom-
ach. Second, DNA from the rodent parasite Plasmodium yoelii
in Aedes mosquitoes (where parasites do not invade the midgut
epithelium and where there is no sporogonic development) is
not detectable by PCR amplification after 5 to 6 days postin-
fection (11). This suggests that the developmental block in the
PfPK7 parasites occurs after the formation of ookinetes and
the invasion of the midgut wall but before the appearance of
mature oocysts. To determine whether the absence of mature
oocysts 10 days postfeeding was due to slow development, we
examined mosquito midguts 16 days postfeeding, but no oo-
cysts were observed even after this prolonged time (data not
shown). Hence, the absence of mature oocysts in mosquitoes
infected with PfPK7 parasites appears to be a consequence of
the inability of the parasite to undergo ookinete-oocyst tran-
sition or subsequent early oocyst development. This may, in
turn, be a consequence of a cell cycle defect: impairment of the
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intense cell division that characterizes sporogony may result in
the parasite’s inability to establish mature oocysts (i.e., that are
detectable by light microscopy examination). Thus, the pheno-
type in sporogony might share a similar molecular basis with
that in erythrocytic schizogony, and PfPK7 may have similar
roles in promoting asexual cell division in the two cases. Fur-
ther work is in progress to validate (or disprove) this hypoth-
esis.
As indicated in Table 1, 1 of the 30 mosquitoes infected with
the B9 clone was oocyst positive. This may be due either to the
partial penetrance of the phenotype or to the sporadic rever-
sion to the wild-type locus by the recombination of the se-
quences that are duplicated in the pseudo-diploid configura-
tion. Such low-level reversion has actually been recently
documented in oocysts obtained from a clone in which the
gametocyte-specific gene Pfg377 is interrupted by a single
crossover recombination and which shows a strong oocyst-
deficient phenotype (5). We were unable to determine whether
this was the explanation for the B9 oocyst-infected mosquito
described in Table 1.
PfPK7 is an “orphan” protein kinase, with no orthologues in
mammalian cells or other eukaryotes. Therefore, its function
cannot be inferred or predicted from that of homologues in
other systems. The present study provides the first step toward
understanding the physiological role of this atypical protein
kinase. On the basis of the data presented here, we can predict
that a PfPK7-specific chemical inhibitor would presumably de-
crease the virulence of the parasite and act as a transmission-
blocking agent, making PfPK7 a potentially interesting target.
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